• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

III 类醇脱氢酶在酒精相关肝病的发生中作为小鼠中的 S-亚硝基谷胱甘肽还原酶发挥关键作用。

Class III Alcohol Dehydrogenase Plays a Key Role in the Onset of Alcohol-Related/-Associated Liver Disease as an S-Nitrosoglutathione Reductase in Mice.

机构信息

Department of Legal Medicine, Kanagawa Dental University, 82 Inaokacho, Yokosuka 238-8580, Japan.

Department of Legal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan.

出版信息

Int J Mol Sci. 2023 Jul 28;24(15):12102. doi: 10.3390/ijms241512102.

DOI:10.3390/ijms241512102
PMID:37569481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10419236/
Abstract

Lipid accumulation in the liver due to chronic alcohol consumption (CAC) is crucial in the development of alcohol liver disease (ALD). It is promoted by the NADH/NAD ratio increase via alcohol dehydrogenase (ADH)-dependent alcohol metabolism and lipogenesis increase via peroxisome proliferator-activated receptor γ (PPARγ) in the liver. The transcriptional activity of PPARγ on lipogenic genes is inhibited by S-nitrosylation but activated by denitrosylation via S-nitrosoglutathione reductase (GSNOR), an enzyme identical to ADH3. Besides ADH1, ADH3 also participates in alcohol metabolism. Therefore, we investigated the specific contribution of ADH3 to ALD onset. ADH3-knockout () and wild-type (WT) mice were administered a 10% ethanol solution for 12 months. exhibited no significant pathological changes in the liver, whereas WT exhibited marked hepatic lipid accumulation ( < 0.005) with increased serum transaminase levels. exhibited no death during CAC, whereas WT exhibited a 40% death. Liver mRNA levels were elevated by CAC in WT ( < 0.01). The alcohol elimination rate measured after injecting 4 g/kg ethanol was not significantly different between two strains, although the rate was increased in both strains by CAC. Thus, ADH3 plays a key role in the ALD onset, likely by acting as GSNOR.

摘要

由于慢性酒精摄入导致的肝脏脂质积累(CAC)在酒精性肝病(ALD)的发展中至关重要。这种积累是通过酒精脱氢酶(ADH)依赖性酒精代谢导致 NADH/NAD 比例增加,以及通过肝脏中的过氧化物酶体增殖物激活受体γ(PPARγ)促进脂肪生成增加而导致的。PPARγ 对脂肪生成基因的转录活性受到 S-亚硝基化的抑制,但通过 S-亚硝基谷胱甘肽还原酶(GSNOR)的去硝基化而被激活,GSNOR 与 ADH3 是同一种酶。除了 ADH1,ADH3 也参与酒精代谢。因此,我们研究了 ADH3 对 ALD 发病的具体贡献。ADH3 敲除()和野生型(WT)小鼠给予 10%乙醇溶液 12 个月。与 WT 相比,没有观察到肝脏的明显病理变化(<0.005),而 WT 表现出明显的肝脂质积累,血清转氨酶水平升高。在 CAC 过程中,没有观察到 WT 的死亡(<0.005),而 WT 表现出 40%的死亡。WT 中的 CAC 导致肝 mRNA 水平升高(<0.01)。在两种品系中,注射 4 g/kg 乙醇后测量的酒精消除率没有显著差异,尽管 CAC 增加了两种品系的消除率。因此,ADH3 在 ALD 的发病中起关键作用,可能通过作为 GSNOR 发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/707228aa4baa/ijms-24-12102-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/22cb2a6106d9/ijms-24-12102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/1d81a0299e9c/ijms-24-12102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/d7bf5ee4015c/ijms-24-12102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/8494105e1fe0/ijms-24-12102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/2c0572fb8dfb/ijms-24-12102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/584de8010679/ijms-24-12102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/707228aa4baa/ijms-24-12102-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/22cb2a6106d9/ijms-24-12102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/1d81a0299e9c/ijms-24-12102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/d7bf5ee4015c/ijms-24-12102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/8494105e1fe0/ijms-24-12102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/2c0572fb8dfb/ijms-24-12102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/584de8010679/ijms-24-12102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e45/10419236/707228aa4baa/ijms-24-12102-g007.jpg

相似文献

1
Class III Alcohol Dehydrogenase Plays a Key Role in the Onset of Alcohol-Related/-Associated Liver Disease as an S-Nitrosoglutathione Reductase in Mice.III 类醇脱氢酶在酒精相关肝病的发生中作为小鼠中的 S-亚硝基谷胱甘肽还原酶发挥关键作用。
Int J Mol Sci. 2023 Jul 28;24(15):12102. doi: 10.3390/ijms241512102.
2
The Contribution of Alcohol Dehydrogenase 3 to the Development of Alcoholic Osteoporosis in Mice.乙醇脱氢酶3对小鼠酒精性骨质疏松症发展的作用
J Nippon Med Sch. 2018;85(6):322-329. doi: 10.1272/jnms.JNMS.2018_85-52.
3
Metabolic pharmacokinetics of early chronic alcohol consumption mediated by liver alcohol dehydrogenases 1 and 3 in mice.早期慢性酒精摄入通过小鼠肝醇脱氢酶 1 和 3 介导的代谢药代动力学。
J Gastroenterol Hepatol. 2018 Nov;33(11):1912-1919. doi: 10.1111/jgh.14260. Epub 2018 May 23.
4
Roles of Two Major Alcohol Dehydrogenases, ADH1 (Class I) and ADH3 (Class III), in the Adaptive Enhancement of Alcohol Metabolism Induced by Chronic Alcohol Consumption in Mice.两种主要的醇脱氢酶(I 类 ADH1 和 III 类 ADH3)在慢性酒精摄入诱导的小鼠酒精代谢适应性增强中的作用。
Alcohol Alcohol. 2020 Feb 7;55(1):11-19. doi: 10.1093/alcalc/agz091.
5
A new view of alcohol metabolism and alcoholism--role of the high-Km Class III alcohol dehydrogenase (ADH3).一种新的酒精代谢和酗酒观点——高 Km 类 III 型酒精脱氢酶(ADH3)的作用。
Int J Environ Res Public Health. 2010 Mar;7(3):1076-92. doi: 10.3390/ijerph7031076. Epub 2010 Mar 15.
6
[Molecular evidences of non-ADH pathway in alcohol metabolism and Class III alcohol dehydrogenase (ADH3)].[酒精代谢中非乙醇脱氢酶途径及Ⅲ类乙醇脱氢酶(ADH3)的分子证据]
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2014 Jun;49(3):159-68.
7
[A new sight on alcohol metabolism and alcoholism--role of high Km alcohol dehydrogenase ADH3 (Class III)].[酒精代谢与酒精中毒的新视角——高Km乙醇脱氢酶ADH3(Ⅲ类)的作用]
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2009 Apr;44(2):78-93.
8
Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.肝脏过氧化物酶体增殖物激活受体γ信号通路促成小鼠酒精性肝脂肪变性和炎症
Alcohol Clin Exp Res. 2016 May;40(5):988-99. doi: 10.1111/acer.13049. Epub 2016 Apr 8.
9
In vivo contribution of Class III alcohol dehydrogenase (ADH3) to alcohol metabolism through activation by cytoplasmic solution hydrophobicity.Ⅲ类乙醇脱氢酶(ADH3)通过细胞质溶液疏水性激活对体内酒精代谢的贡献。
Biochim Biophys Acta. 2006 Mar;1762(3):276-83. doi: 10.1016/j.bbadis.2005.11.008. Epub 2006 Jan 4.
10
Linking Dysregulated AMPK Signaling and ER Stress in Ethanol-Induced Liver Injury in Hepatic Alcohol Dehydrogenase Deficient Deer Mice.酒精脱氢酶缺乏型鹿鼠乙醇诱导肝损伤中 AMPK 信号失调与内质网应激的关联。
Biomolecules. 2019 Oct 2;9(10):560. doi: 10.3390/biom9100560.

引用本文的文献

1
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer.酒精代谢酶、肝脏疾病与癌症
Semin Liver Dis. 2025 Mar;45(1):99-113. doi: 10.1055/a-2551-3320. Epub 2025 Mar 29.

本文引用的文献

1
Lipid droplet dynamics in alcoholic fatty liver disease.酒精性脂肪性肝病中的脂滴动力学
Liver Res. 2019 Dec;3(3-4):185-190. doi: 10.1016/j.livres.2019.09.002. Epub 2019 Sep 6.
2
Roles of Two Major Alcohol Dehydrogenases, ADH1 (Class I) and ADH3 (Class III), in the Adaptive Enhancement of Alcohol Metabolism Induced by Chronic Alcohol Consumption in Mice.两种主要的醇脱氢酶(I 类 ADH1 和 III 类 ADH3)在慢性酒精摄入诱导的小鼠酒精代谢适应性增强中的作用。
Alcohol Alcohol. 2020 Feb 7;55(1):11-19. doi: 10.1093/alcalc/agz091.
3
A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease.
过氧化物酶体增殖物激活受体 γ 在非酒精性脂肪性肝病中的作用。
Basic Clin Pharmacol Toxicol. 2019 May;124(5):528-537. doi: 10.1111/bcpt.13190. Epub 2019 Jan 22.
4
Pathophysiological Role of S-Nitrosylation and Transnitrosylation Depending on S-Nitrosoglutathione Levels Regulated by S-Nitrosoglutathione Reductase.取决于由亚硝基谷胱甘肽还原酶调节的亚硝基谷胱甘肽水平,亚硝基化和转亚硝基化的病理生理作用
Biomol Ther (Seoul). 2018 Nov 1;26(6):533-538. doi: 10.4062/biomolther.2018.179.
5
Metabolic pharmacokinetics of early chronic alcohol consumption mediated by liver alcohol dehydrogenases 1 and 3 in mice.早期慢性酒精摄入通过小鼠肝醇脱氢酶 1 和 3 介导的代谢药代动力学。
J Gastroenterol Hepatol. 2018 Nov;33(11):1912-1919. doi: 10.1111/jgh.14260. Epub 2018 May 23.
6
The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.S-亚硝基谷胱甘肽还原酶(GSNOR)在人类疾病与治疗中的作用。
Crit Rev Biochem Mol Biol. 2017 Jun;52(3):340-354. doi: 10.1080/10409238.2017.1304353. Epub 2017 Apr 10.
7
Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis.抑制 PPARγ 介导的单酰甘油 O-酰基转移酶 1 表达可改善酒精性肝脂肪变性。
Sci Rep. 2016 Jul 11;6:29352. doi: 10.1038/srep29352.
8
Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.肝脏过氧化物酶体增殖物激活受体γ信号通路促成小鼠酒精性肝脂肪变性和炎症
Alcohol Clin Exp Res. 2016 May;40(5):988-99. doi: 10.1111/acer.13049. Epub 2016 Apr 8.
9
Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen.内源性甲醛是一种造血干细胞基因毒素和代谢致癌物。
Mol Cell. 2015 Oct 1;60(1):177-88. doi: 10.1016/j.molcel.2015.08.020. Epub 2015 Sep 24.
10
Nitric oxide in liver diseases.肝脏疾病中的一氧化氮
Trends Pharmacol Sci. 2015 Aug;36(8):524-36. doi: 10.1016/j.tips.2015.05.001. Epub 2015 May 28.